SCHEMBL25515569

SCHEMBL25515569

CCOC(=O)CC/C(=N\O)C(=O)c1ccc2c(c1)c1cc(C(=O)c3ccc(O)cc3)ccc1n2CC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
HPGD P15428 3/20 0.44
HTT P42858 3/20 0.44
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 2/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
RCE1 Q9Y256 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41
TUBA3E Q6PEY2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515473 0.89 KDM4E (0.50) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL25515465 0.86 KDM4E (0.47) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL25515458 0.86 KDM4E (0.51) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL25515727 0.85 CNR2 (0.48) KDM4EHPGDHTTMAPTLMNA
SCHEMBL23801779 0.84 CNR2 (0.47) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL25515451 0.84 CNR2 (0.47) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL25515570 0.82 TUBB4A (0.43) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL25515445 0.82 KDM4E (0.47) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL25515468 0.80 HPGD (0.56) KDM4EHPGDHTTMAPTSMN1; SMN2
SCHEMBL23801803 0.80 CNR2 (0.41) KDM4EHPGDHTTMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS OCIAD1, OCIAD2, OXER1 KDM4E 1857/4885HPGD 362/4885HTT 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.